The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12625000893404
Ethics application status
Approved
Date submitted
18/06/2025
Date registered
18/08/2025
Date last updated
18/08/2025
Date data sharing statement initially provided
18/08/2025
Type of registration
Retrospectively registered

Titles & IDs
Public title
FareShare Medically Tailored Meals Pilot Program for Type 2 Diabetes
Scientific title
FareShare Medically Tailored Meals Pilot Program for Type 2 Diabetes: A pilot feasibility study
Secondary ID [1] 314661 0
Nil
Universal Trial Number (UTN)
Trial acronym
FareShareMTM Pilot
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Type 2 Diabetes 337836 0
Condition category
Condition code
Metabolic and Endocrine 334169 334169 0 0
Diabetes

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Within the scope of this jointly led community-based, non-randomised clinical pilot feasibility study, the 12-week medically tailored meals intervention comprises weekly direct delivery of ready-made meals prepared by chefs at FareShare—the meal provider and research partner in this pilot. Meals are prepared and cooked onsite and stored, and delivered to recipients frozen, ready to be heated by recipients. Meals are prepared according to recipes developed jointly by FareShare chefs and study dietitians in line with evidence-based nutritional recommendations for the management of type 2 diabetes. FareShare will use donated and purchased ingredients and produce grown in their kitchen gardens. The intervention will provide participants—adults living in inner and parts of Greater Melbourne with diagnosed, undermanaged type 2 diabetes and who have trouble accessing nutritious foods with two main meals (lunch and dinner) and two snacks daily, five days a week. Our referral partner site dietitians from community health organisations—cohealth and Holstep Health will identify, pre-screen and refer clients within their networks diagnosed with type 2 diabetes and ongoing hyperglycaemia who face challenges accessing or preparing nutritious food, according to their clinical judgement and will administer the Hunger Vital Signs screening tool. With their client’s verbal permission, the study team will contact the referred client to explain the study requirements, provide the Participant Information and Consent Form, obtain informed consent and complete eligibility screening.
Enrolled participants will then be contacted by a member of the FareShare operational project team to provide information about meal ordering and delivery processes. Participants will self-order weekly boxes by calling FareShare via a dedicated phone line coordinated and monitored by FareShare, which will oversee and facilitate meal ordering and coordinate delivery logistics. Participants can order meals weekly or up to two weeks ahead by phone by selecting meals from a menu of four meal set options comprising meals aligned with the Australian Dietary Guidelines and prepared using additional guidelines from the National Diabetes Service and Diabetes Australia - Carbohydrate counting and diabetes 2016. A meal box of 10 frozen meals and 10 snacks (5x30g portions of mixed nuts and 5 pieces of seasonal fruit) will be delivered directly to the participant's home address weekly for 12 weeks in consultation with the participant to ensure they are available within the delivery days and windows to receive the meal box.
As part of the intervention, participants will be contacted by phone at Weeks 1 and 4 by the meal provider to review meal satisfaction via three short routine monitoring questions, taking up to 15 minutes. Moreover, participants will be contacted at Weeks 2, 6 and 8 by the study team to review their consumption of meals and provide their feedback regarding meal satisfaction. Calls to participants at Weeks 2 and 8 will be conducted by a study dietitian providing auxiliary dietary support, including an individually tailored dietary consultation as part of the intervention and also to encourage meal uptake and support healthier food choices. The dietary consults aim to ask participants three routine monitoring questions related to consumption and satisfaction with the delivered MTMs. That is, 1) Can you tell me what you thought about the healthy meals provided in the last few weeks (briefly note response, i.e, satisfied or not satisfied); 2) In the last week, of the 10 meals provided, how many healthy meals did you eat? (Write down the number and reason if provided.) If a reason is not provided, participants will be asked a third question, i.e., 3) Can you tell me more about why you did not eat (X number) of meals in the last week? Reasons will be noted by the dietitian, e.g., bad taste or was in hospital for a few days or not delivered, etc. Study dietitians will also consult with participants and provide healthy eating advice and resources as required around their topics of interest or queries. For example, regarding meal timing, other meals, snacks and fluids consumed alongside the MTMs, including on the two non-prescribed meal days as directed by the participant's queries. Examples of available resources include (but are not limited to) Baker Institute Factsheets regarding 'Dietary Fibre', 'Healthy Snacks', as well as an 'Eating Out Guide' by Diabetes Australia, 'Breakfast Ideas' and 'Healthy Snacks and Meal Ideas' developed by the National Diabetes Services Scheme. The duration of this call will be up to 30 minutes. If resources are provided in response to the participant's queries, the relevant information will be either posted or emailed, depending on the needs of the participant. In Weeks 6 and 13, participants will complete a short process evaluation questionnaire, which will take up to 15 minutes.
Intervention code [1] 331287 0
Lifestyle
Comparator / control treatment
NIL
Control group
Uncontrolled

Outcomes
Primary outcome [1] 341825 0
Acceptability of the 12-week intervention.
Timepoint [1] 341825 0
Routine monitoring questions will be completed at Weeks 1, 2, 4 and 8. Dietary consultations take place during the Week 2 and 8 call for routine monitoring questions. A process evaluation questionnaire will be completed at Week 6. A process evaluation interview will be completed at Week 13 i.e., 12 weeks post-commencement of the intervention with participants and key informants including program implementers, healthcare providers and kitchen and delivery staff.
Primary outcome [2] 341826 0
Accessibility of the 12-week intervention
Timepoint [2] 341826 0
Routine monitoring questions will be completed at Weeks 1, 2, 4 and 8. Dietary consultations take place during the Week 2 and 8 call for completion of the routine monitoring questions. A process evaluation questionnaire will be completed at Week 6. A process evaluation interview will be completed at Week 13 i.e., 12 weeks post-commencement of the intervention with participants and a key informants including program implementers, healthcare providers and kitchen and delivery staff.
Primary outcome [3] 342372 0
Change in diet quality.
Timepoint [3] 342372 0
At baseline and week 13 i.e, 12 weeks post commencement of the intervention
Secondary outcome [1] 448785 0
Food security
Timepoint [1] 448785 0
At baseline and week 13 i.e, 12 weeks post commencement of the intervention
Secondary outcome [2] 448843 0
Nutrition security
Timepoint [2] 448843 0
At baseline and week 13 i.e, 12 weeks post commencement of the intervention
Secondary outcome [3] 448844 0
Changes in clinical indicators, a composite of all clinical indicators - HbA1c, lipid panel, blood pressure and body weight
Timepoint [3] 448844 0
At baseline and week 13 i.e, 12 weeks post commencement of the intervention
Secondary outcome [4] 448845 0
Changes in patient-reported outcome measure related to generic health status.
Timepoint [4] 448845 0
At baseline and week 13 i.e, 12 weeks post commencement of the intervention
Secondary outcome [5] 449371 0
Changes in patient-reported outcome measure related to general emotional well-being
Timepoint [5] 449371 0
At baseline and week 13 i.e, 12 weeks post commencement of the intervention
Secondary outcome [6] 449372 0
Changes in patient-reported outcome measure related to diabetes distress
Timepoint [6] 449372 0
At baseline and week 13 i.e, 12 weeks post commencement of the intervention

Eligibility
Key inclusion criteria
1. Individuals aged 18 years or older.
2. Lives in a suburb within FareShare’s meal delivery zone.
3. Able to communicate in English at a conversational level that does not require an interpreter or translation support (based on the healthcare provider’s judgment).
4. Clinically diagnosed with type 2 diabetes for at least 12 months
5. Persistently high blood glucose defined as HbA1c of 7.0% or higher at their most recent
clinical assessment within the past 6 months.
6. Have difficulties accessing and eating nutritious food based on the following:
-Healthcare provider’s clinical judgement and, a food insecurity screener (Hunger Vital Signs) – administered by the clinician, e.g., site dietitian.
7. Lives alone (or with a household carer or partner).
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Are unable or unwilling to provide informed consent.
2. Will require an interpreter and translation support.
3. Not planning to stay within their home in inner Melbourne for the next 6 months.
4. Are in hospice or palliative care.
5. Live in a facility that provides most or all of their meals.
6. Does not have a freezer for storing study meals.
7. Pregnant women (or lactating).
8. Are caring for dependents/children.
9. Have existing medical condition(s) that limit dietary intake or require an individualised diet(s).
10. Have active cancer, severe chronic kidney disease (stage 4 or worse) or heart
failure.
11. Have severe food allergies
12. Are participating in other lifestyle modification trials.

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
Primary analyses will assess the feasibility and acceptability of the intervention by describing referral rates, time to meet the target sample, attrition rates, dietary counselling participation rates, number of adverse events, and the acceptability of the MTMs as measured by routine monitoring data, a process evaluation questionnaire, and in-depth semi-structured interviews with a subset of key informants. Primary analyses will be performed on the AHEI and food insecurity score to assess the change in these outcomes from baseline to week 13, assessed using paired t-tests.

Recruitment
Recruitment status
Active, not recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 319224 0
Charities/Societies/Foundations
Name [1] 319224 0
FareShare
Country [1] 319224 0
Australia
Primary sponsor type
Other Collaborative groups
Name
The George Institute of Global Health
Address
Country
Australia
Secondary sponsor category [1] 321716 0
None
Name [1] 321716 0
None
Address [1] 321716 0
Country [1] 321716 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 317803 0
The University of New South Wales Research Ethics Committee A
Ethics committee address [1] 317803 0
Ethics committee country [1] 317803 0
Australia
Date submitted for ethics approval [1] 317803 0
17/02/2025
Approval date [1] 317803 0
24/04/2025
Ethics approval number [1] 317803 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 142206 0
Dr Antonia Thodis
Address 142206 0
The George Institute for Global Health, Level 8, 55 Botany Street, Randwick, New South Wales 2031, Australia
Country 142206 0
Australia
Phone 142206 0
+61 2 8052 4358
Fax 142206 0
Email 142206 0
Contact person for public queries
Name 142207 0
Antonia Thodis
Address 142207 0
The George Institute for Global Health, Level 8, 55 Botany Street, Randwick, New South Wales 2031, Australia
Country 142207 0
Australia
Phone 142207 0
+61 2 8052 4358
Fax 142207 0
Email 142207 0
Contact person for scientific queries
Name 142208 0
Antonia Thodis
Address 142208 0
The George Institute for Global Health, Level 8, 55 Botany Street, Randwick, New South Wales 2031, Australia
Country 142208 0
Australia
Phone 142208 0
+61 2 8052 4358
Fax 142208 0
Email 142208 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.